Search Results

Nuplazid (pimavanserin) is used to help manage symptoms of psychosis, such as hallucinations, in patients suffering from Parkinson’s disease. However, the antipsychotic drug’s clinical trial resulted in alarming side effects—including death. Despite some medical professionals’ concerns about the safety and effectiveness of the drug, Nuplazid was approved by the U.S. Food and Drug Administration (FDA) in 2016. Since then, reports (more...)